112 related articles for article (PubMed ID: 22032838)
1. There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.
Meiser B; Gleeson M; Kasparian N; Barlow-Stewart K; Ryan M; Watts K; Menon D; Mitchell G; Tucker K
Gynecol Oncol; 2012 Jan; 124(1):153-7. PubMed ID: 22032838
[TBL] [Abstract][Full Text] [Related]
2. Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
Gleeson M; Meiser B; Barlow-Stewart K; Trainer AH; Tucker K; Watts KJ; Friedlander M; Kasparian N
Oncol Nurs Forum; 2013 May; 40(3):275-83. PubMed ID: 23619104
[TBL] [Abstract][Full Text] [Related]
3. Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
Meiser B; Gleeson M; Watts K; Peate M; Zilliacus E; Barlow-Stewart K; Saunders C; Mitchell G; Kirk J
Oncol Nurs Forum; 2012 Mar; 39(2):E101-11. PubMed ID: 22374498
[TBL] [Abstract][Full Text] [Related]
4. Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.
Zilliacus E; Meiser B; Gleeson M; Watts K; Tucker K; Lobb EA; Mitchell G
Support Care Cancer; 2012 Nov; 20(11):2949-58. PubMed ID: 22441502
[TBL] [Abstract][Full Text] [Related]
5. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
[TBL] [Abstract][Full Text] [Related]
6. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
7. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
[TBL] [Abstract][Full Text] [Related]
8. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
[TBL] [Abstract][Full Text] [Related]
9. An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.
Brain K; Gravell C; France E; Fiander A; Gray J
Gynecol Oncol; 2004 Mar; 92(3):905-13. PubMed ID: 14984959
[TBL] [Abstract][Full Text] [Related]
10. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C
Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048
[TBL] [Abstract][Full Text] [Related]
11. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
12. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.
Hamann HA; Croyle RT; Venne VL; Baty BJ; Smith KR; Botkin JR
Am J Med Genet; 2000 May; 92(1):25-32. PubMed ID: 10797419
[TBL] [Abstract][Full Text] [Related]
13. Five families living with hereditary breast and ovarian cancer risk.
Norris J; Spelic SS; Snyder C; Tinley S
Clin J Oncol Nurs; 2009 Feb; 13(1):73-80. PubMed ID: 19193551
[TBL] [Abstract][Full Text] [Related]
14. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
15. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
[TBL] [Abstract][Full Text] [Related]
16. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
17. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Watts KJ; Meiser B; Mitchell G; Kirk J; Saunders C; Peate M; Duffy J; Kelly PJ; Gleeson M; Barlow-Stewart K; Rahman B; Friedlander M; Tucker K;
BMC Cancer; 2012 Jul; 12():320. PubMed ID: 22838957
[TBL] [Abstract][Full Text] [Related]
18. Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.
Tinelli A; Malvasi A; Leo G; Vergara D; Pisanò M; Ciccarese M; Chiuri VE; Lorusso V
Cancer Metastasis Rev; 2010 Jun; 29(2):339-50. PubMed ID: 20405170
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
van Roosmalen MS; Stalmeier PF; Verhoef LC; Hoekstra-Weebers JE; Oosterwijk JC; Hoogerbrugge N; Moog U; van Daal WA
J Clin Oncol; 2004 Aug; 22(16):3293-301. PubMed ID: 15310772
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
